Skip to main content
CELL BIOTECH CO ., LTD logo

CELL BIOTECH CO ., LTD — Investor Relations & Filings

Ticker · 049960 ISIN · KR7049960008 KO Manufacturing
Open in API
Filings indexed 189 across all filing types
Latest filing 2025-07-25 Annual Report
Country KR South Korea
Listing KO 049960

About CELL BIOTECH CO ., LTD

https://www.cellbiotech.com/

CELL BIOTECH CO., LTD. is a biotechnology company specializing in the research, development, and manufacturing of probiotic solutions. With over three decades of experience, the company leverages its proprietary, worldwide-patented dual-coating technology, which is designed to ensure a higher survival rate for probiotic strains as they pass through the gastrointestinal tract. The company develops and utilizes its own GRAS (Generally Recognized as Safe) certified strains for its products. Its business encompasses the production of finished consumer products, such as the DUOLAC brand, and providing customized OEM/ODM services for the pharmaceutical and food supplement sectors.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for an Annual Report (사업보고서) filed by Cell Biotech. It explicitly references the original Annual Report filed on March 19, 2025, and provides corrections to specific sections (such as treasury stock reporting). In the context of financial filings, a correction to an Annual Report is classified under the same category as the report itself, which is the 10-K (Annual Report). FY 2024
2025-07-25 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Cell Biotech' (쎌바이오텍) covering the period from January 1, 2025, to March 31, 2025. It contains detailed business descriptions, financial data, product information, and research and development activities. As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. Q1 2025
2025-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (영업(잠정)실적) for Cell Biotech, detailing quarterly financial performance metrics such as revenue, operating profit, and net income. It is a short, structured announcement of financial results rather than a full annual or interim report. According to the filing definitions, this fits the 'Earnings Release' (ER) category. Q1 2025
2025-05-09 Korean
소속부변경
Regulatory Filings Classification · 100% confidence The document is a short, structured announcement regarding a change in the company's market classification (from 'Large-cap' to 'Venture' status) on the stock exchange. It does not contain full financial statements or detailed reports, but rather serves as a regulatory notification of a corporate status change. As it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2025-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding status of a specific individual (Jung Yu-sook) who was newly appointed as a director at Cellbiotech. This type of filing is a standard regulatory requirement for directors and major shareholders to disclose their personal shareholdings and changes therein, which corresponds to the 'Director's Dealing' (DIRS) category.
2025-04-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership of an individual (Jung Hye-ji) who has been newly appointed as a registered director of Cellbiotech. This type of filing is a standard regulatory requirement for reporting insider holdings and changes in ownership by company directors, which falls under the 'Director's Dealing' category.
2025-04-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.